Application of T cell-based transcriptomics to identify three candidate biomarkers for monitoring anti-TGFβR therapy

Abstract

Overall, the proposed concept of biomarker identification can be easily adapted towards other drug candidates for whom gene regulation can be established in cellular components of peripheral blood.